The Discounted Cash Flow (DCF) valuation of AFT Pharmaceuticals Ltd (AFT.NZ) is 3.13 NZD. With the latest stock price at 3.36 NZD, the upside of AFT Pharmaceuticals Ltd based on DCF is -6.8%.
Based on the latest price of 3.36 NZD and our DCF valuation, AFT Pharmaceuticals Ltd (AFT.NZ) is a sell. selling AFT.NZ stocks now will result in a potential gain of 6.8%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 10.3% | 8.8% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 2.06 - 6.26 | 3.13 |
| Upside | -38.7% - 86.2% | -6.8% |